Literature DB >> 17425630

Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells.

José A Guerrero1, Leyre Navarro-Nuñez, María L Lozano, Constantino Martínez, Vicente Vicente, Jonathan M Gibbins, José Rivera.   

Abstract

AIMS: Flavonoids may affect platelet function by several mechanisms, including antagonism of TxA(2) receptors (TP). These TP are present in many tissues and modulate different signalling cascades. We explored whether flavonoids affect platelet TP signalling, and if they bind to TP expressed in other cell types.
METHODS: Platelets were treated with flavonoids, or other selected inhibitors, and then stimulated with U46619. Similar assays were performed in aspirinized platelets activated with thrombin. Effects on calcium release were analysed by fluorometry and changes in whole protein tyrosine phosphorylation and activation of ERK 1/2 by Western blot analysis. The binding of flavonoids to TP in platelets, human myometrium and TPalpha- and TPbeta-transfected HEK 293T cells was explored using binding assays and the TP antagonist (3)H-SQ29548.
RESULTS: Apigenin, genistein, luteolin and quercetin impaired U46619-induced calcium mobilization in a concentration-dependent manner (IC(50) 10-30 microm). These flavonoids caused a significant impairment of U46619-induced platelet tyrosine phosphorylation and of ERK 1/2 activation. By contrast, in aspirin-treated platelets all these flavonoids, except quercetin, displayed minor effects on thrombin-induced calcium mobilization, ERK 1/2 and total tyrosine phosphorylation. Finally, apigenin, genistein and luteolin inhibited by >50% (3)H-SQ29548 binding to different cell types.
CONCLUSIONS: These data further suggest that flavonoids may inhibit platelet function by binding to TP and by subsequent abrogation of downstream signalling. Binding of these compounds to TP occurs in human myometrium and in TP-transfected HEK 293T cells and suggests that antagonism of TP might mediate the effects of flavonoids in different tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17425630      PMCID: PMC2000638          DOI: 10.1111/j.1365-2125.2007.02881.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  48 in total

Review 1.  Dietary components and human platelet activity.

Authors:  Asim K Dutta-Roy
Journal:  Platelets       Date:  2002-03       Impact factor: 3.862

2.  Role of the ERK pathway in the activation of store-mediated calcium entry in human platelets.

Authors:  J A Rosado; S O Sage
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

Review 3.  Cell signalling through thromboxane A2 receptors.

Authors:  Jin-Sheng Huang; Santosh K Ramamurthy; Xin Lin; Guy C Le Breton
Journal:  Cell Signal       Date:  2004-05       Impact factor: 4.315

4.  Genistein and daidzein modulate in vitro rat uterine contractile activity.

Authors:  C Picherit; M Dalle; G Néliat; P Lebecque; M J Davicco; J P Barlet; V Coxam
Journal:  J Steroid Biochem Mol Biol       Date:  2000-12-15       Impact factor: 4.292

5.  Thromboxane receptor signalling in human myometrial cells.

Authors:  Frances Moore; Gergely Asbóth; Bernal Andrés López
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-01       Impact factor: 3.072

6.  Flavonoid inhibition of platelet procoagulant activity and phosphoinositide synthesis.

Authors:  R Bucki; J J Pastore; F Giraud; J-C Sulpice; P A Janmey
Journal:  J Thromb Haemost       Date:  2003-08       Impact factor: 5.824

7.  Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway.

Authors:  G P Hubbard; J M Stevens; M Cicmil; T Sage; P A Jordan; C M Williams; J A Lovegrove; J M Gibbins
Journal:  J Thromb Haemost       Date:  2003-05       Impact factor: 5.824

8.  Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets.

Authors:  Archibald McNicol; Elke C G Jackson
Journal:  Biochem Pharmacol       Date:  2003-04-15       Impact factor: 5.858

9.  Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.

Authors:  Séverine Roger; Marc Pawlowski; Aïda Habib; Martine Jandrot-Perrus; Jean Philippe Rosa; Marijke Bryckaert
Journal:  FEBS Lett       Date:  2004-01-02       Impact factor: 4.124

10.  Dietary phytoestrogens and their synthetic structural analogues as calcium channel blockers in human platelets.

Authors:  Yuliya Dobrydneva; Roy L Williams; Gary Z Morris; Peter F Blackmore
Journal:  J Cardiovasc Pharmacol       Date:  2002-09       Impact factor: 3.105

View more
  18 in total

1.  Effects of apigenin on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells.

Authors:  Wei Li; Akhilesh K Pandey; Xiangling Yin; Jau-Jiin Chen; Douglas M Stocco; Paula Grammas; Xingjia Wang
Journal:  J Nutr Biochem       Date:  2011-03       Impact factor: 6.048

Review 2.  Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs.

Authors:  Bernice Wright; Jeremy P E Spencer; Julie A Lovegrove; Jonathan M Gibbins
Journal:  Cardiovasc Res       Date:  2012-09-27       Impact factor: 10.787

3.  Platelet-mediated metabolism of the common dietary flavonoid, quercetin.

Authors:  Bernice Wright; Trevor Gibson; Jeremy Spencer; Julie A Lovegrove; Jonathan M Gibbins
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

4.  Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets.

Authors:  L Navarro-Núñez; J Rivera; J A Guerrero; C Martínez; V Vicente; M L Lozano
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

5.  Molecular docking, molecular modeling, and molecular dynamics studies of azaisoflavone as dual COX-2 inhibitors and TP receptor antagonists.

Authors:  Murtuza Hadianawala; Amarjyoti Das Mahapatra; Jitender K Yadav; Bhaskar Datta
Journal:  J Mol Model       Date:  2018-02-26       Impact factor: 1.810

Review 6.  Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease.

Authors:  Scott Gleim; Zsolt Kasza; Kathleen Martin; John Hwa
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

7.  Revisiting the mechanistic basis of the French Paradox: Red wine inhibits the activity of protein disulfide isomerase in vitro.

Authors:  Christine N Galinski; Jeffrey I Zwicker; Daniel R Kennedy
Journal:  Thromb Res       Date:  2015-11-07       Impact factor: 3.944

8.  Plant food delphinidin-3-glucoside significantly inhibits platelet activation and thrombosis: novel protective roles against cardiovascular diseases.

Authors:  Yan Yang; Zhenyin Shi; Adili Reheman; Joseph W Jin; Conglei Li; Yiming Wang; Marc C Andrews; Pingguo Chen; Guangheng Zhu; Wenhua Ling; Heyu Ni
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  Dual Roles of Quercetin in Platelets: Phosphoinositide-3-Kinase and MAP Kinases Inhibition, and cAMP-Dependent Vasodilator-Stimulated Phosphoprotein Stimulation.

Authors:  Won Jun Oh; Mehari Endale; Seung-Chun Park; Jae Youl Cho; Man Hee Rhee
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-17       Impact factor: 2.629

10.  Non-steroid anti-inflammatory drugs, prostaglandins, and cancer.

Authors:  Viola Allaj; Changxiong Guo; Daotai Nie
Journal:  Cell Biosci       Date:  2013-02-06       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.